DCF — LEWIS GALE MEDICAL CENTER
Enterprise Value: $492.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$492.1M
Enterprise Value
$134.8M
PV of Cash Flows
$357.3M
PV of Terminal Value
$575.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $417.2M | $58.5M | 14.0% | $28.8M | $26.2M |
| Year 2 | $429.7M | $64.5M | 15.0% | $32.9M | $27.2M |
| Year 3 | $442.6M | $70.9M | 16.0% | $37.2M | $27.9M |
| Year 4 | $455.8M | $75.3M | 17.0% | $40.0M | $27.3M |
| Year 5 | $469.5M | $78.7M | 17.0% | $42.1M | $26.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $492.1M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$405.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1351685339082503
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5